文献速递血液净化与透析慢性肾脏病

终末期肾病整合肾脏支持治疗的随机对照试验

Randomized Controlled Trial of Integrated Kidney Supportive Care in End-Stage Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2026-07-08

该随机对照试验在印度三级医院纳入成人肾衰竭患者,比较整合肾脏支持治疗与常规护理对生活质量、症状负担及预立医疗照护计划参与度的影响。结果显示整合肾脏支持治疗组生活质量显著改善、症状负担显著降低,且预立医疗照护计划讨论与记录意愿显著提高。

要点

  • 整合肾脏支持治疗可显著改善终末期肾病患者生活质量。
  • 整合肾脏支持治疗可显著降低患者症状负担。
  • 整合肾脏支持治疗提高预立医疗照护计划参与度及心肺复苏拒绝率。

核心结论

  • 整合肾脏支持治疗改善生活质量、降低症状负担并提高预立医疗照护计划参与度。

研究设计与样本

  • 随机对照试验,在印度三级医院开展,纳入成人肾衰竭患者,采用区组随机分组。

主要发现

  • 干预组生活质量评分较基线和对照组显著提高(P < 0.01)。
  • 干预组症状负担较基线和对照组显著降低(P < 0.01)。
  • 干预组预立医疗照护计划讨论与记录意愿显著增加,心肺复苏拒绝率显著更高,接受呼吸机或ICU入住意愿降低(P < 0.01)。

临床怎么用

  • 在发展中地区可将结构化肾脏支持治疗整合入常规肾脏护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Kidney failure is linked to a substantial symptom burden and diminished quality of life (QoL). The incorporation of kidney supportive care (KSC) and advance care planning (ACP) into routine nephrology practices could enhance patient-centered outcomes; however, data from developing countries are scarce. This study evaluated the effects of KSC versus standard care on QoL, symptom burden, and ACP engagement in kidney failure. METHODS: This randomized controlled trial was conducted at a tertiary care hospital in India from June 2023 to June 2025. Adult patients with kidney failure were randomized using block randomization to receive either integrated KSC or conventional care. Outcomes, including QoL, symptom burden, and ACP engagement, were assessed at baseline and at 2, 4, and 6 months using the Edmonton Symptom Assessment System-revised (ESAS-r) Renal tool, EuroQol 5-Dimensions, 5-Levels (EQ-5D-5L), and an ACP questionnaire. RESULTS: Patients in the intervention group showed significant improvements across multiple domains, with QoL scores increasing markedly (P < 0.01) and symptom burden decreasing significantly (P < 0.01) compared with baseline and the control group. Additionally, the willingness of patients to engage in ACP discussions and documentation increased substantially in the KSC group, which was accompanied by a significantly higher rate of Cardiopulmonary Resuscitation refusal and a reduced willingness for ventilator or intensive care unit (ICU) admission (P < 0.01). CONCLUSION: Integrated KSC improves QoL, reduces symptom burden, and enhances ACP engagement. These findings support integrating structured KSC into routine kidney care in developing settings.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Naik B, Nagaraju SP, Damani A, et al. Randomized Controlled Trial of Integrated Kidney Supportive Care in End-Stage Kidney Disease. Kidney Int Rep. 2026. PMID: 42602446. doi:10.1016/j.ekir.2026.106696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。